Filing Details

Accession Number:
0000950170-23-013527
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-04-19 17:32:22
Reporting Period:
2023-04-17
Accepted Time:
2023-04-19 17:32:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1521036 Lantheus Holdings Inc. LNTH In Vitro & In Vivo Diagnostic Substances (2835) 352318913
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1861389 Etienne Montagut C/O Lantheus Holdings, Inc.
201 Burlington Road, South Bldg
Bedford MA 01730
Chief Business Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-04-17 2,118 $88.67 67,254 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 24, 2023.